Citations 4

External Support for Saphenous Vein Grafts in Coronary Artery Bypass Surgery

JAMA Cardiology | June 8, 2022 | Volume: 7 | Issue: 8 | Pages: 808

10.1001/jamacardio.2022.1437 | PMID 35675092

Cardiac surgeons' concerns, perceptions, and responses during the COVID‐19 pandemic

Journal of Cardiac Surgery | June 12, 2021 | Volume: 36 | Issue: 9 | Pages: 3040-3051

10.1111/jocs.15681 | PMID 34118080

Volume-Outcome Association of Mitral Valve Surgery in the United States

JAMA Cardiology | July 1, 2020 | Volume: 5 | Issue: 10 | Pages: 1092

10.1001/jamacardio.2020.2221 | PMID 32609292

Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves

Circulation | January 22, 2018 | Volume: 137 | Issue: 4 | Pages: 388-399

10.1161/circulationaha.117.030729 | PMID 29358344

Bioprostheses are prone to structural valve degeneration, resulting in limited long-term durability. A significant challenge when comparing the durability of different types of bioprostheses is the lack of a standardized terminology for the definition of a degenerated valve. This issue becomes especially important when we try to compare the degeneration rate of surgically inserted and transcatheter bioprosthetic valves. This document, by the VIVID (Valve-in-Valve International Data), proposes practical and standardized definitions of valve degeneration and provides recommendations for the timing of clinical and imaging follow-up assessments accordingly. Its goal is to improve the quality of research and clinical care for patients with deteriorated bioprostheses by providing objective and strict criteria that can be utilized in future clinical trials. We hope that the adoption of these criteria by both the cardiological and surgical communities will lead to improved comparability and interpretation of durability analyses.